Cefiderocol sulfate tosylate - Generic Drug Details

What are the generic drug sources for cefiderocol sulfate tosylate and what is the scope of patent protection?

Cefiderocol sulfate tosylate is the generic ingredient in one branded drug marketed by Shionogi Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cefiderocol sulfate tosylate has seventy-nine patent family members in thirty-six countries.

One supplier is listed for this compound.

Summary for cefiderocol sulfate tosylate

International Patents:	79
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in cefiderocol sulfate tosylate?	cefiderocol sulfate tosylate excipients list
DailyMed Link:	cefiderocol sulfate tosylate at DailyMed

Pharmacology for cefiderocol sulfate tosylate

Drug Class

Cephalosporin Antibacterial

US Patents and Regulatory Information for cefiderocol sulfate tosylate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes			Y	Y
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes			Y	Y
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes			Y
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes

International Patents for cefiderocol sulfate tosylate

Country	Patent Number	Title	Estimated Expiration
Costa Rica	20110144	CEFALOSPORIN TENIENDO GRUPO CATECOL
South Korea	20180088750	세팔로스포린 유도체의 염, 그의 결정성 고체 및 그의 제조 방법 (SALT OF CEPHALOSPORIN DERIVATIVE CRYSTALLINE SOLID FORM OF SAME AND METHOD FOR PRODUCING SAME)
Hungary	E031802
Eurasian Patent Organization	019520	ЦЕФАЛОСПОРИНЫ, СОДЕРЖАЩИЕ КАТЕХОЛЬНУЮ ГРУППУ (CEPHALOSPORIN HAVING CATECHOL GROUP)
South Korea	101935186
Japan	6120429
World Intellectual Property Organization (WIPO)	2016035845

Supplementary Protection Certificates for cefiderocol sulfate tosylate

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2960244	43/2020	Austria		PRODUCT NAME: CEFIDEROCOL, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATS; REGISTRATION NO/DATE: EU/1/20/1434 (MITTEILUNG) 20200424
2960244	301067	Netherlands		PRODUCT NAME: CEFIDEROCOL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/20/1434 20200424
2960244	C20200033 00355	Estonia		PRODUCT NAME: TSEFIDEROKOOL;REG NO/DATE: EU/1/20/1434 24.04.2020
2960244	C202030051	Spain		PRODUCT NAME: CEFIDEROCOL, OPCIONALMENTE EN FORMA DE UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE.; NATIONAL AUTHORISATION NUMBER: EU/1/20/1434; DATE OF AUTHORISATION: 20200423; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1434; DATE OF FIRST AUTHORISATION IN EEA: 20200423
2960244	2020/044	Ireland		PRODUCT NAME: CEFIDEROCOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; NAT REGISTRATION NO/DATE: EU/1/20/1434 20200424; FIRST REGISTRATION NO/DATE: EU/1/20/1434 20200424
2960244	PA2020530	Lithuania		PRODUCT NAME: CEFIDEROKOLAS, PASIRINKTINAI FARMACISKAI PRIIMTINOS DRUSKOS ARBA SOLVATO PAVIDALU; REGISTRATION NO/DATE: EU/1/20/1434 20200423
2960244	2090041-1	Sweden		PRODUCT NAME: CEFIDEROKOL; REG. NO/DATE: EU/1/20/1434 20200424